Skip to main content
. Author manuscript; available in PMC: 2012 Aug 9.
Published in final edited form as: Acta Oncol. 2011 Jun;50(Suppl 1):39–48. doi: 10.3109/0284186X.2011.572914

Figure 4.

Figure 4

(A). CRPC patient with multiple osteoblastic metastases. Sagittal fused PET/CT and PET images (FDG top row, FDHT bottom row) demonstrate prominent FDG and FDHT uptake, consistent with a “Glycolysis/AR Concordant” phenotype. (B). Second CRPC patient with multiple osteoblastic metastases. Sagittal fused PET/CT and PET images (FDG top row, FDHT bottom row) demonstrate intense FDHT uptake and relatively low level FDG uptake, consistent with an “AR Predominant” phenotype.